#NewAseBioMember | “AseBio is the meeting point and driving force behind biotechnology in Spain”

AseBio. What does your company's work bring to the table and what is its strength?

Marta Dueñas. At Danae Urogenomics, we bring innovation to patients by offering more accurate, non-invasive, and personalised bladder cancer diagnoses. This improves quality of life and makes the best use of healthcare resources.

AseBio. What is AseBio for you?

Marta Dueñas. For us, AseBio represents a strategic network that connects companies, researchers, institutions and administrations with a common goal: to put innovation at the service of society.  It is the meeting point and driving force behind biotechnology in Spain, a space where we can connect, collaborate and grow in the service of innovation and society.

AseBio. When did you first hear about AseBio?

Marta Dueñas. We first heard about AseBio from other startup friends in the sector, who told us how the association had helped them connect and grow.

AseBio. What do you expect from being part of an association like AseBio?

Marta Dueñas. By joining AseBio, we hope to contribute to the development of the Spanish biotechnology ecosystem, generating synergies with other entities and accessing opportunities for collaboration in research, innovation, and technology transfer. We also trust that it will help us gain greater visibility, institutional representation, and support in our internationalisation efforts.

AseBio. What is the biggest challenge facing the biotech sector or your company?

Marta Dueñas. For us, the big challenge is to ensure that innovation truly reaches patients. It is not enough to have a good idea or a good test; you have to overcome regulatory barriers, secure funding, and demonstrate its value in clinical practice. That is the most difficult path, but also the most necessary one.